AFP and hepatocellular carcinoma: However, AFP showed much poorer diagnostic performance than the biomarker panel in discriminating small MetS(+) HCC from MetS, and the AUC, sensitivity and specificity were 0.67, 54.55% and 76.00%, respectively (Figure 5B and Table 4).